




Научные результаты биомедицинских исследований. 2021;7(2):111-116 









DOI: 10.18413/2658-6533-2021-7-2-0-1               УДК 618.39-021.3 
 
Association of VEGFA, factor V  
and prothrombin gene polymorphisms with 









Peoples’ Friendship University of Russia, 
6 Miklukho-Maklaya St., Moscow, 117198, Russia 
Corresponding author: Abdulbary A.M. Ahmed (bariiameen@hotmail.com) 
 
Abstract 
Background: Many studies conducted to assess the associations between the gene 
polymorphisms of factor V, prothrombin, and vascular endothelial growth factor 
gene A and recurrent early pregnancy loss (REPL) have shown conflicting findings. 
The aim of the study: We designed this study and selected the most common pol-
ymorphisms that have been analyzed before, VEGFA −2578C/A (rs699947), VEG-
FA 936C/T (rs3025039), FVL G1691A (rs6025), and prothrombin FII G20210A 
(rs1799963) to be the candidate genetic polymorphisms for analysis of their associ-
ation with idiopathic early pregnancy loss in Russian women. Materials and 
methods: 100 women with idiopathic early pregnancy loss were enrolled and clas-
sified into two subgroups: sporadic early pregnancy loss (SEPL), consisting of 50 
women, and recurrent early pregnancy loss (REPL), consisting of 50 women. The 
control group included 56 women with full-term babies. Genotyping was performed 
using commercially available kits (Syntol, Russia) for Real time-PCR method. 
Genotype and allele distributions in studied groups were compared using the chi-
square test and Fisher’s exact test. The tests and calculation of Odds ratio with 95% 
confidence intervals (CIs) were conducted employing the statistical software SPSS, 
version 22. Results: The heterozygous genotype (CA) for VEGFA rs699947 was 
significantly associated with REPL. Findings have shown that women carrying the 
heterozygous genotype had a higher REPL risk (OR 9.04, 95% CI 4.33-18.7). No 
significant associations with SEPL or REPL were found for the other studied poly-
morphisms. Conclusion: Our findings suggest that heterozygosity for VEGFA 
rs699947 gene polymorphism may play a role in predisposition to idiopathic early 
pregnancy loss and can be a genetic risk factor for recurrent early miscarriage in 
Russian women. 
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Introduction. Early pregnancy loss 
(EPL), defined as the spontaneous failure of a 
pregnancy within the first 12 weeks of gesta-
tion, is an important reproductive problem 
happening roughly in 10% of all clinically 
recognized pregnancies and 80% of all preg-
nancy loss cases [1]. Such a loss is called spo-
radic early pregnancy loss (SEPL) when it 
occurs once in nonconsecutive rounds of ges-
tations, affecting 25-50% of all reproductive-
age women, but when it happens two or more 
times called recurrent early pregnancy loss 
(REPL), affecting 2-5% of couples seeking 
pregnancy [1, 2]. Until now, a variety of 
causative factors have been explained to be 
implicated in pregnancy abortion, including 
uterine anomalies, endocrine and autoimmune 
disorders, acquired and hereditary thrombo-
philias, in addition to nutritional and lifestyle 
factors, but only 50% of EPL causes could be 
identified [2, 3]. 
To achieve a successful pregnancy, it 
requires from placenta to develop and func-
tion properly. The placenta may lose its per-
fusion function as a result of formation of mi-
crothrombi in the placental vascular bed, 
causing serious complications such as abrup-
tion of placenta, fetal growth restriction, and 
pregnancy loss. Thrombophilia is a predispo-
sition to the development of thrombosis 
caused by inherited and acquired defects in 
clotting process. Inherited thrombophilia oc-
curs due to various disorders of blood coagu-
lation, encompassing the mutation of factor V 
(FV), the prothrombin (FII), and shortage of 
the plasma anticoagulants, such as antithrom-
bin, protein S, and protein C. Within these 
abnormalities, Factor V Leiden (FVL 
G1691A) and FII G20210A are comparatively 
common, whereas the others are infrequent. 
The involvement of inherited thrombophilia 
in early abortion and vascular disorders dur-
ing pregnancy has been screened in several 
studies that have found an association be-
tween inherited thrombophilia and recurrent 
early abortion [4], while the other has not [5], 
therefore the findings appear to be incon-
sistent.  
To ensure the progressive development 
of gestation needs that the implanting embryo 
must induce the capillaries formation through 
the angiogenesis process for providing its 
blood supply. The best-reported inducer of 
angiogenesis is the vascular endothelial 
growth factor (VEGFA). VEGFA is an effi-
cient proangiogenic glycoprotein exerting a 
proliferative effect on endothelial cells resid-
ing in pre-existing blood vessels and therefore 
induces fetal-maternal blood vessel formation 
in the uterus [6]. During early pregnancy, 
VEGFA is secreted from the ovarian follicles 
and embryonic trophoblast; it plays a vital 
role in the maturation of oocytes, the prolifer-
ation of trophoblast, the increase of vascular 
permeability and endothelial cell proliferation 
resulting in successful embryo implantation as 
well as in maintaining growth and develop-
ment of embryo through the establishment of 
normal chorionic villous vascularization [7].  
Many polymorphisms have been re-
vealed to influence the activity and expression 
of the VEGFA gene. Some studies have not 
found any association between REPL and 
VEGFA -2578 C/A, VEGFA 936C/T poly-
morphisms [8], while others found that VEG-
FA -2578C/A and VEGFA 936C/T were asso-
ciated [9, 10]. Recently, a study found that the 
VEGFA 936C/T was associated with REPL 
whereas the VEGFA -2578C/A was not [11], 
however, another study performed on Russian 
women found that VEGFA -2578C/A was as-
sociated with increased risk of first-trimester 
pregnancy loss [12].  
The inconsistencies in all aforemen-
tioned genetic studies’ findings of the impli-
cation of gene polymorphisms of VEGFA, 
factor V, and prothrombin in the pathogenesis 
of early abortion led to trouble obtaining a 
correct assessment of their association with 
REPL.  
The aim of the study. We designed this 
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polymorphisms that have been analyzed be-
fore, VEGFA −2578C/A (rs699947), VEGFA 
936C/T (rs3025039), in addition to such clot-
ting factors as Factor V (FVL G1691A 
rs6025) and prothrombin (FII G20210A 
rs1799963) to be the candidate genetic poly-
morphisms for an analysis of their association 
with idiopathic early pregnancy loss in Rus-
sian women.  
Materials and methods. Participants 
and samples. We conducted a case-control 
study to analyze VEGFA gene polymorphisms 
(VEGFA −2578C/A rs699947, VEGFA 
936C/T rs3025039, Factor V Leiden (FVL 
G1691A rs6025), and prothrombin (FII 
G20210A rs1799963) to reassess whether the-
se polymorphisms are maternal risk factors 
for EPL and REPL in Russian women from 
Central Russia. All women subjected to this 
study gave informed consent for participation. 
The approval to conduct this study was given 
by the Ethics Committee of the Institute of 
Medicine of RUDN University. The study 
was conducted on DNA samples from 100 
women who suffered from early pregnancy 
loss (EPL) that happened within the first 12 
weeks of pregnancy with an average age of 
31.5±4.9 years. The case group was classified 
into two groups: one group called SEPL refer-
ring to women with a single non-successive 
pregnancy loss, included 50 participants, and 
the second group called REPL referring to 
women with two or more consecutive preg-
nancy losses, consisted of 50 participants that 
involved women with primary REPL, those 
who had not ever had full-term pregnancy and 
women with secondary REPL, those who had 
at least one viable fetus prior to miscarriages. 
The etiological agent of miscarriage could not 
be diagnosed by classical criteria for early 
miscarriage evaluation. All early abortion 
cases experienced chronic diseases were not 
included in the study. 56 age-matched healthy 
women 29.2±3.5 years were enrolled as a 
control group, they had normal pregnancies 
and no past history of previous miscarriage or 
any other reproductive problems. 
DNA extraction and genotyping of 
SNPs. Genomic DNA was extracted from pe-
ripheral blood samples using a standard pro-
cedure of a commercially available kit (Syn-
tol, Russia). Extracted DNA was stored at −20 
°C. Genotyping for VEGFA rs699947, VEG-
FA rs3025039, FVL rs6025, and FII 
rs1799963 was performed using commercial-
ly available kits for Real time-PCR (Syntol, 
Russia). 
Statistical analysis. Allele and genotype 
frequencies for studied polymorphisms in 
cases and controls were computed. Genotype 
and allele distributions in studied groups were 
compared using the chi-square test (Χ
2
). Fish-
er’s exact test was used when the frequencies 
were less than 5%. The tests and calculation 
of Odds ratio with 95% confidence intervals 
(CIs) were conducted employing the statisti-
cal software SPSS, version 22. P-values ≤ 
0.05 were considered statistically significant. 
Results and discussion. Genotype and 
allele frequencies for studied polymorphisms 
are shown in table.  
The findings of the study have not rec-
orded any significant differences in the distri-
butions of the wild genotype (GG) and the 
heterozygous genotype (GA) for Factor V 
Leiden (FVL) rs6025 polymorphism between 
all the studied groups. Similarly, no signifi-
cant differences were found for FII rs1799963 
polymorphism. The minor homozygous geno-
type (AA) for both polymorphisms was not 
detected in any of the studied groups. 
A significant difference in the genotype 
frequencies for VEGFA rs699947 polymor-
phism was shown in women with REPL (CC 
16.0%, CA 72.0%, AA 12.0%, P<0.05) when 
compared with those in healthy women (CC 
30.4%, CA 46.4%, AA 23.2%). What is strik-
ing in the result that the incidence of the het-
erozygous genotype was significantly higher, 
while the wild and minor homozygous geno-
types were less frequent among women with 
recurrent early pregnancy loss than those in 
healthy women. The findings have revealed 
that the heterozygous genotype was highly 
associated with the increased risk of recurrent 
early miscarriage in the carrier women (OR 
9.04, 95% CI 4.33-18.7). No significant dif-
ferences were found in the distribution of dif-
ferent genotypes and alleles for VEGFA 
rs3025039 polymorphism in all studied pa-
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Table 
Genotype and allele frequencies (%) for FVL rs6025, FII rs1799963, VEGFA rs3025039,  
and VEGFA rs699947 gene polymorphisms in studied groups 
Note: *- p<0.05 in comparison with control 
 
To maintain the growth and develop-
ment of a fetus, a new blood vessel plexus 
should be formed in the chorionic villous. 
VEGFA is a survival factor for endothelial 
cells and plays also a crucial role in inducing 
growth of the maternal and fetal blood vessels 
in the uterus during placenta formation as 
well as supports embryo development via an-
giogenesis and vasculogenesis [7]. Several 
studies have reported that functional poly-
morphisms of the VEGFA gene may have a 
part in the pathogenesis of REPL. It has been 
found that VEGFA −2578C/A (rs699947) and 
936C/T (rs3025039) polymorphisms have an 
adjusting influence on the level of the VEGF 
gene expression, where noticed the occur-
rence of VEGFA 936T (rs3025039) in the 3′-
untranslated region (3′UTR) or VEGFA –
2578A (rs699947) in the promoter region of 
VEGFA gene results in the lowered expres-
sion of VEGFA gene and as a result reduced 
production of the corresponding protein [8]. 
The current study results have shown 
that frequencies of homozygotes for VEGFA 
–2578C/A (rs699947) were significantly low-
er, while heterozygotes were significantly 
more frequent in women with recurrent preg-
nancy loss than those in women of the control 
group (P-value 0.029). It was found in a study 
that the occurrence of A allele at –2578-
position is associated with a decreased level 
of VEGF mRNA expression and as a result 
CA genotype at this site may lead to slightly 
decreased VEGF protein concentration. Ac-
cordingly, VEGFA protein level produced in 
heterozygous becomes not sufficient for com-
plete angiogenesis and may lead to inadequate 
fetoplacental vascularization and gestation 
failure [12]. This explanation may present a 
clarification for the increased heterozygous 
genotype level in REPL women whereas can-
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not interpret the increased AA genotype level 
in healthy women. Based on the genetic belief 
that REPL is a polygenic problem and there 
must be various gene defects that contribute 
to its onset, we can suppose that the higher 
occurrence of AA genotype among healthy 
women might not be enough to cause recur-
rent miscarriages in the absence of the other 
integrative risk agents. Further, we recom-
mend analyzing the VEGFA rs699947 poly-
morphism in a larger sample size. 
This study findings support those pub-
lished by an author who conducted a study 
on Russian women, where reported that the 
–2578 heterozygote (CA) frequency was 
significantly higher whereas the homozy-
gous genotype (AA) was lower in REPL 
women compared to healthy women [12]. 
Likewise, another study found a deficiency 
in the –2578 AA genotype incidence among 
women with REPL comparing with that in 
healthy women [9]. 
The FVL rs6025 (G1691A) and FII 
rs1799963 (G20210A) polymorphisms are 
the most common abnormalities in FV and 
FII genes, where FII rs1799963 arises due to 
the substitution of G with A at position 20210 
in the 3’- untranslated region of the pro-
thrombin gene causing an elevation in plas-
ma prothrombin concentration by 20% – 
50% and FVL rs6025 is a missense mutation 
resulting in the production of a malfunction-
ing protein, which resists inhibiting effect by 
active protein C [4]. Our findings did not 
show any association between these poly-
morphisms and any of the early pregnancy 
loss types, which coincide with another study 
findings that did not reveal the association, 
too [5]. Thus, the results indicate that the 
studied patients suffering from idiopathic 
miscarriages did not have the most common 
genetic variants leading to hereditary throm-
bophilia.  
Conclusion. Our findings suggest that 
heterozygosity for VEGFA rs699947 gene pol-
ymorphism may play a role in predisposition to 
idiopathic early pregnancy loss and can be a 
genetic risk factor for recurrent early miscar-
riage in Russian women.  
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